The Alzheimer’s disease-like AsymAD cases show a higher frequency of the APOE ε4 allele but are otherwise indistinguishable from the Control-like AsymAD cases based on demographics, cognitive performance, or level of CSF Aβ42, tTau, or pTau (Supplemental Fig. 1). This evidence concerns the gene APOE and Alzheimer disease.